Who owns Vera Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of VERA from SEC Form 13F filings across 220 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 220 institutions disclosed 77.9M shares of Vera Therapeutics, Inc. worth $3.34B — about 108.5% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
220
13F holders
$3.34B
value, 2026 filers
108.5%
of shares outstanding (77.9M sh)
30
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of VERA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 5.7M | $246.6M | 0.0% | 8% | +13.0% |
| 2 | Avoro Capital Advisors LLC | 5.7M | $245.6M | 2.2% | 8% | -2.8% |
| 3 | STATE STREET CORP | 4.1M | $178.0M | 0.0% | 5.8% | +23.3% |
| 4 | PRICE T ROWE ASSOCIATES INC /MD/ | 4.0M | $172.2M | 0.0% | 5.6% | -12.3% |
| 5 | Deep Track Capital, LP | 4.0M | $171.6M | 2.5% | 5.6% | -2.6% |
| 6 | DEERFIELD MANAGEMENT COMPANY, L.P. | 3.9M | $168.1M | 1.8% | 5.5% | +5.2% |
| 7 | Kynam Capital Management, LP | 2.9M | $124.0M | 6.9% | 4% | -15.0% |
| 8 | MORGAN STANLEY | 2.8M | $120.1M | 0.0% | 3.9% | +659.2% |
| 9 | Sofinnova Investments, Inc. | 2.8M | $119.9M | 6.2% | 3.9% | 0.0% |
| 10 | FMR LLC | 2.8M | $119.0M | 0.0% | 3.9% | +3.6% |
| 11 | VANGUARD CAPITAL MANAGEMENT LLC | 2.8M | $118.2M | 0.0% | 3.8% | +2.7% |
| 12 | Eversept Partners, LP | 2.2M | $94.9M | 4.9% | 3.1% | +1.8% |
| 13 | Logos Global Management LPNEW | 2.2M | $94.4M | 4.1% | 3.1% | new |
| 14 | Integral Health Asset Management, LLC | 1.8M | $75.1M | 3.0% | 2.4% | +9.4% |
| 15 | Bellevue Group AG | 1.7M | $73.4M | 1.5% | 2.4% | 0.0% |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | 1.7M | $72.6M | 0.0% | 2.4% | +7.8% |
| 17 | ALLIANCEBERNSTEIN L.P. | 1.6M | $64.0M | 0.0% | 2.2% | +21.1% |
| 18 | GOLDMAN SACHS GROUP INC | 1.4M | $59.3M | 0.0% | 1.9% | +21.8% |
| 19 | FRONTIER CAPITAL MANAGEMENT CO LLC | 1.3M | $55.6M | 0.5% | 1.8% | +134.9% |
| 20 | Pictet Asset Management Holding SA | 1.2M | $53.6M | 0.1% | 1.7% | +18.8% |
| 21 | DEUTSCHE BANK AG\ | 1.1M | $47.3M | 0.0% | 1.5% | +107.0% |
| 22 | Qube Research & Technologies Ltd | 1.1M | $46.5M | 0.0% | 1.5% | +99.9% |
| 23 | Woodline Partners LP | 1.0M | $43.0M | 0.1% | 1.4% | 0.0% |
| 24 | AMERICAN CENTURY COMPANIES INC | 866,243 | $37.2M | 0.0% | 1.2% | +18.9% |
| 25 | VANGUARD PORTFOLIO MANAGEMENT LLC | 642,873 | $27.6M | 0.0% | 0.9% | +16.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.